• Search by category

  • Show all

Thanks for all your involvement in 2013 and our hopes for 2014

December 20, 2013
 - Tim Hardman

With the year coming to a close, the Niche team are eager to thank all our colleagues, partners and fellow science-enthusiasts for their engagement over the last 12 months and share our greetings for the season (what we at Niche call Niche-mas as a time when we take a break and reflect on the year that has just passed).

Looking back, 2013 has been a great year for Niche. We started the year with our grant-funded Frailomic research programme being approved by the European Union Horizon 20-20 fund. We followed this by rapid take up of the project as we onboarded the various consortium partners from across Europe. We also had several manuscripts published that were written by the Niche team on subjects like lipid-lowering and diabetes. We have also published several blogs on issues such as poster design techniques and the new Good Publications Practice.

Looking ahead to 2013, it looks like we have an exciting year ahead. We are still waiting to hear from the EU on our IMI grant application, SPRINTT, looking at biomarkers relating to muscle strength and early-onset frailty. We also have several blogs planned detailing best practice on a variety of industry activities and several new review manuscripts in advanced stages of development. We hope to continue to release more of our industry leading Insider’s Insights – so remember to sign up for our email updates here.

Ultimately, it has been another successful year for Niche, as we continue to innovate and expand our ever-growing portfolio of projects and 2014 offers exciting initiatives to come. That leaves us with the one pleasant task of share our best wishes for the next year, where we hope we can continue working with the broader scientific, medical and pharma community. In the words of Norman Vincent Peale, “I truly believe that if we keep telling the Christmas story, singing the Christmas songs, and living the Christmas spirit, we can bring joy and happiness and peace to this world.”

About the author

Tim Hardman
Managing Director
View profile
Dr Tim Hardman is Managing Director of Niche Science & Technology Ltd., a bespoke services CRO based in the UK, and a keen and occasional commentator on science, business and the process of drug development. He also serves occasionally as acting Scientific Director for the healthcare agency Phase II International, specialising in medical strategy and communication.

Related Articles

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility